Prescription Drug Overdose Prevention for States | Apply Online

Opportunity Information: Apply for CDC RFA CE15 1501

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Prescription Drug Overdose Prevention for States" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.136 Injury Prevention and Control Research and State and Community Based Programs.
• This funding opportunity was created on May 27, 2015 and posted on Mar 6, 2015.
• Applicants must submit their applications by Jun 2, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2024.)
• The funding agency has allocated a total of $55,600,000.00 to eligible and selected applicants.
• Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
• The number of recipients for this funding is limited to 16 candidate(s).
• Eligible applicants include: State governments.
• Current Boost States States funded under the Boost FOA (CDC RFA CE14 1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from A state level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities. The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the statersquos PDMP. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workersrsquo Compensation program, provide a LOS from the Workersrsquo Compensation authority. If the applicant is integrating and/or disseminating evidence based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authorityrsquos support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agencyrsquos support and agreement to share data for evaluation purposes.

Apply for CDC RFA CE15 1501

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: